Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'antipsychotics' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 523 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Felice Vadruccio; Giovanni Biricolti; Leonardo Mendolicchio
      Analisi farmacoeconomica del trattamento di pazienti psicotici cronici con olanzapina, antipsicotici atipici e neurolettici tipici: uno studio regionale

      Farmeconomia e percorsi terapeutici
    2. Fear, C
      Managing schizophrenia: an update

      HOSPITAL MEDICINE
    3. Ghaemi, SN
      On defining 'mood stabilizer'

      BIPOLAR DISORDERS
    4. Peuskens, J; De Hert, M; Jones, M
      The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    5. Basile, VS; Ozdemir, V; Masellis, M; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, FM; Petronis, A; Kennedy, JL
      Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

      MOLECULAR PSYCHIATRY
    6. Strakowski, SM; DelBello, MP; Adler, CM
      Comparative efficacy and tolerability of drug treatments for bipolar disorder

      CNS DRUGS
    7. Onrust, SV; McClellan, K
      Perospirone

      CNS DRUGS
    8. Noordsy, DL; O'Keefe, C; Mueser, KT; Xie, HY
      Six-month outcomes for patients who switched to olanzapine treatment

      PSYCHIATRIC SERVICES
    9. Osser, DN; Sigadel, R
      Short-term inpatient pharmacotherapy of schizophrenia

      HARVARD REVIEW OF PSYCHIATRY
    10. Edell, WS; Tunis, SL
      Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    11. Mouallem, M; Wolf, I
      Olanzapine-induced respiratory failure

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    12. Reeves, RR; Mack, JE; Torres, RA
      Neuroleptic malignant syndrome during a change from haloperidol to risperidone

      ANNALS OF PHARMACOTHERAPY
    13. Domon, SE; Webber, JC
      Hyperglycemia and hypertriglyceridemia secondary to olanzapine

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    14. Robinet, EA; Wurch, T; Pauwels, PJ
      Different regulation of RGS2 mRNA by haloperidol and clozapine

      NEUROREPORT
    15. Bustillo, JR; Lauriello, J; Rowland, LM; Jung, RE; Petropoulos, H; Hart, BL; Blanchard, J; Keith, SJ; Brooks, WM
      Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia

      PSYCHIATRY RESEARCH-NEUROIMAGING
    16. Aleman, A; Kahn, RS
      Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    17. Schreinzer, D; Frey, R; Stimpfl, T; Vycudilik, W; Berzlanovich, A; Kasper, S
      Different fatal toxicity of neuroleptics identified by autopsy

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    18. Liebzeit, KA; Markowitz, JS; Caley, CF
      New onset diabetes and atypical antipsychotics

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    19. Naber, D; Karow, A
      Good tolerability equals good results: the patient's perspective

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    20. Kane, JM
      Extrapyramidal side effects are unacceptable

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    21. Kasper, S; Tauscher, J; Heiden, A
      Quetiapine: efficacy and tolerability in schizophrenia

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    22. Lynch, J; Morrison, J; Graves, N; Meddis, D; Drummond, MF; Hellewell, JSE
      The health economic implications of treatment with quetiapine: an audit oflong-term treatment for patients with chronic schizophrenia

      EUROPEAN PSYCHIATRY
    23. Allain, H; Schuck, S; Mauduit, N; Djemai, M
      Comparative effects of pharmacotherapy on the maintenance of cognitive function

      EUROPEAN PSYCHIATRY
    24. Robert, PH; Allain, H
      Clinical management of agitation in the elderly with tiapride

      EUROPEAN PSYCHIATRY
    25. Konicki, PE; Kwon, KY; Steele, V; White, J; Fuller, M; Jurjus, GJ; Jaskiw, GE
      Prefrontal cortical sulcal widening associated with poor treatment response to clozapine

      SCHIZOPHRENIA RESEARCH
    26. Cuesta, MJ; Peralta, V; Zarzuela, A
      Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study

      SCHIZOPHRENIA RESEARCH
    27. Sacristan, A; Gomez, JC; Badia, X; Kind, P
      Global index of safety (GIS): A new instrument to assess drug safety

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    28. Wadenberg, MLG; Soliman, A; VanderSpek, SC; Kapur, S
      Dopamine D-2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects

      NEUROPSYCHOPHARMACOLOGY
    29. Jaskiw, GE; Collins, KA; Pehek, EA; Yamamoto, BK
      Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: An in vivo microdialysis study

      NEUROPSYCHOPHARMACOLOGY
    30. Baldessarini, RJ; Campbell, A; Webb, NL; Swindell, CS; Flood, JG; Shashoua, VE; Kula, NS; Hemamalini, S; Bradley, MO
      Fatty acid derivatives of clozapine: Prolonged antidopaminergic activity of docosahexaenoylclozapine in the rat

      NEUROPSYCHOPHARMACOLOGY
    31. Roberts, RC
      Effect of chronic olanzapine treatment on striatal synaptic organization

      SYNAPSE
    32. Hansen, L
      A critical review of akathisia, and its possible association with suicidalbehaviour

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    33. Chae, BJ; Kang, BJ
      The effect of clozapine on blood glucose metabolism

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    34. Lindstrom, E; Lewander, T; Malm, U; Malt, UF; Lublin, H; Ahlfors, UG
      Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia - Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat)

      NORDIC JOURNAL OF PSYCHIATRY
    35. Anjum, R; Roy, A; Marston, G
      Antipsychotic induced priapism in a man with an intellectual disability

      IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE
    36. Labelle, A; Light, M; Dunbar, F
      Risperidone treatment of outpatients with schizophrenia: No evidence of sex differences in treatment response

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    37. Lesage, AD; Stip, E; Grunberg, F
      What's up, doc? Context, limitations, and issues for clinicians in evidence-based medicine

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    38. Procyshyn, RM; Kennedy, NB; Tse, G; Thompson, B
      Antipsychotic polypharmacy: A survey of discharge prescriptions from a tertiary care psychiatric institution

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    39. McIntyre, RS; McCann, SM; Kennedy, SH
      Antipsychotic metabolic effects: Weight gain, diabetes mellitus, and lipidabnormalities

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    40. Bolos, J; Princep, M; Guglietta, A
      Abaperidone hydrochloride. Antipsychotic, dopamine D-2 antagonist, 5-HT2A antagonist

      DRUGS OF THE FUTURE
    41. Valevski, A; Loebl, T; Keren, T; Bodinger, L; Weizman, A
      Response of catatonia to risperidone: Two case reports

      CLINICAL NEUROPHARMACOLOGY
    42. Sa, DS; Kapur, S; Lang, AE
      Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis

      CLINICAL NEUROPHARMACOLOGY
    43. Mitchell, PB
      Therapeutic drug monitoring of psychotropic medications

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    44. Esel, E; Basturk, M; Gonul, AS; Kula, M; Turan, MT; Yabanoglu, I; Sofuoglu, S
      Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients

      PSYCHONEUROENDOCRINOLOGY
    45. Robinet, EA; Geurts, M; Maloteaux, JM; Pauwels, PJ
      Chronic treatment with certain antipsychotic drugs preserves upregulation of regulator of G-protein signalling 2 mRNA in rat striatum as opposed to c-fos mRNA

      NEUROSCIENCE LETTERS
    46. Liao, DL; Yeh, YC; Chen, HM; Chen, H; Hong, CJ; Tsai, SJ
      Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

      NEUROPSYCHOBIOLOGY
    47. Lecrubier, Y; Azorin, M; Bottai, T; Dalery, J; Garreau, G; Lemperiere, T; Lisoprawski, A; Petitjean, F; Vanelle, JM
      Consensus on the practical use of amisulpride, an atypical antipsychotic, in the treatment of schizophrenia

      NEUROPSYCHOBIOLOGY
    48. Ahlenius, S; Ericson, E
      Scopolamine does not restore normal conditioned avoidance performance in raclopride-treated rats

      JOURNAL OF NEURAL TRANSMISSION
    49. Hassin-Baer, S; Sirota, P; Korczyn, AD; Treves, TA; Epstein, B; Shabtai, H; Martin, T; Litvinjuk, Y; Giladi, N
      Clinical characteristics of neuroleptic-induced parkinsonism

      JOURNAL OF NEURAL TRANSMISSION
    50. Green, B
      Focus on ziprasidone

      CURRENT MEDICAL RESEARCH AND OPINION
    51. Remington, G; Khramov, I
      Health care utilization in patients with schizophrenia maintained on atypical versus conventional antipsychotics

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    52. Barbui, C; Guaiana, G; Garatini, S
      Regulatory issues in Europe

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    53. McCartan, D; Bell, R; Green, JF; Campbell, C; Trimble, K; Pickering, A; King, DJ
      The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers

      JOURNAL OF PSYCHOPHARMACOLOGY
    54. Wilton, LV; Heeley, EL; Pickering, RM; Shakir, SA
      Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine

      JOURNAL OF PSYCHOPHARMACOLOGY
    55. Ahmed, Z; Anderson, IM
      Treatment of bipolar affective disorder in clinical practice

      JOURNAL OF PSYCHOPHARMACOLOGY
    56. Petty, F; Brannan, S; Casada, J; Davis, LL; Gajewski, V; Kramer, GL; Stone, RC; Teten, AL; Worchel, J; Young, KA
      Olanzapine treatment for post-traumatic stress disorder: an open-label study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    57. Kasper, S; Rosillon, D; Duchesne, I
      Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    58. Kasper, S; Jones, M; Duchesne, I
      Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): health economic results of an international naturalistic study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    59. Barbui, C; Campomori, A; Mezzalira, L; Lopatriello, S; Da Cas, R; Garattini, S
      Psychotropic drug use in Italy, 1984-99: the impact of a change in reimbursement status

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    60. Kasper, S; Quiner, S; Barnas, C; Fabisch, T; Haushofer, M; Sackel, C; Konig, P; Lingg, A; Platz, T; Rittmannsberger, H; Stuppack, C; Willeit, M; Zapotoczky, HG
      Zotepine in the treatment of acute hospitalized schizophrenic episodes

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    61. Mir, S; Taylor, D
      Atypical antipsychotics and hyperglycaemia

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    62. Kodesh, A; Finkel, B; Lerner, AG; Kretzmer, G; Sigal, M
      Dose-dependent olanzapine-associated leukopenia: three case reports

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    63. Kane, J
      Progress defined - short-term efficacy, long-term effectiveness

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    64. Canas, F
      Sustaining short-term gains for future progress

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    65. Casey, DE
      Barriers to progress - the impact of tolerability problems

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    66. Wallace, M
      Real progress - the patient's perspective

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    67. Mooren, R; Verhoeven, WMA; Tuinier, S; van den Berg, YWMM; Fekkes, D; Pepplinkhuizen, L
      Olanzapine in relapsing schizophrenia. Efficacy and serotonergic parameters

      EUROPEAN JOURNAL OF PSYCHIATRY
    68. Garcia-Anaya, M; Apiquian, R; Fresan, A
      Atypical anti-psychotics: review article.

      SALUD MENTAL
    69. Gareri, P; Cotroneo, A; Marchisio, U; Curcio, M; De Sarro, G
      Risperidone in the treatment of behavioral disorders in elderly patients with dementia

      ARCHIVES OF GERONTOLOGY AND GERIATRICS
    70. Bourin, M; Dhonnchadha, BAN; Colombel, MC; Dib, M; Hascoet, M
      Cyamemazine as an anxiolytic drug on the elevated plus maze and light/darkparadigm in mice

      BEHAVIOURAL BRAIN RESEARCH
    71. Fontaine, KR; Heo, M; Harrigan, EP; Shear, CL; Lakshminarayanan, M; Casey, DE; Allison, DB
      Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate

      PSYCHIATRY RESEARCH
    72. Tohen, M; Zhang, F; Taylor, CC; Burns, P; Zarate, C; Sanger, T; Tollefson, G
      A meta-analysis of the use of typical antipsychotic agents in bipolar disorder

      JOURNAL OF AFFECTIVE DISORDERS
    73. Ozdemir, V; Basile, VS; Masellis, M; Kennedy, JL
      Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes

      JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
    74. Angelo, HR; Petersen, A
      Therapeutic drug monitoring of haloperidol, perphenazine, and zuclopenthixol in serum by a fully automated sequential solid phase extraction followedby high-performance liquid chromatography

      THERAPEUTIC DRUG MONITORING
    75. Narendran, R; Young, CM; Valenti, AM; Pristach, CA; Pato, MT; Grace, JJ
      Olanzapine therapy in treatment-resistant psychotic mood disorders: A long-term follow-up study

      JOURNAL OF CLINICAL PSYCHIATRY
    76. Kingsbury, SJ; Fayek, M; Trufasiu, D; Zada, J; Simpson, GM
      The apparent effects of ziprasidone on plasma lipids and glucose

      JOURNAL OF CLINICAL PSYCHIATRY
    77. Sanger, TM; Grundy, SL; Gibson, PJ; Namjoshi, MA; Greaney, MG; Tohen, MF
      Long-term olanzapine therapy in the treatment of bipolar I disorder: An open-label continuation phase study

      JOURNAL OF CLINICAL PSYCHIATRY
    78. Budman, CL; Gayer, A; Lesser, M; Shi, QH; Bruun, RD
      An open-label study of the treatment efficacy of olanzapine for Tourette'sdisorder

      JOURNAL OF CLINICAL PSYCHIATRY
    79. Currier, GW; Simpson, GM
      Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation

      JOURNAL OF CLINICAL PSYCHIATRY
    80. Davis, JM; Chen, N
      The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: Combined results of the North American and international trials

      JOURNAL OF CLINICAL PSYCHIATRY
    81. Allison, DB; Casey, DE
      Antipsychotic-induced weight gain: A review of the literature

      JOURNAL OF CLINICAL PSYCHIATRY
    82. Sauriol, L; Laporta, M; Edwardes, MD; Deslandes, M; Ricard, N; Suissa, S
      Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: Evaluating the indirect approach

      CLINICAL THERAPEUTICS
    83. Mullen, J; Jibson, MD; Sweitzer, D
      A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: The Quetiapine Experience with Safety and Tolerability (QUEST) study

      CLINICAL THERAPEUTICS
    84. Mansbach, RS; Carver, J; Zorn, SH
      Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    85. Alves, CRR; Silva, MTA
      Facilitation of latent inhibition by the atypical antipsychotic risperidone

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    86. Parnetti, L; Amici, S; Lanari, A; Gallai, V
      Pharmacological treatment of non-cognitive disturbances in dementia disorders

      MECHANISMS OF AGEING AND DEVELOPMENT
    87. Rojas, P; Arancibia, P; Bravo, V; Varela, S
      Diabetes mellitus associated with olanzapine use

      REVISTA MEDICA DE CHILE
    88. Labbate, LA; Lare, SB
      Sexual dysfunction in male psychiatric outpatients: Validity of the Massachusetts General Hospital Sexual Functioning Questionnaire

      PSYCHOTHERAPY AND PSYCHOSOMATICS
    89. Schafer, M; Schmidt, F; Grunze, H; Laakmann, G; Loeschke, K
      Interferon-alpha associated with agranulocytosis during medication with clozapine

      NERVENARZT
    90. Glick, ID; Murray, SR; Vasudevan, P; Marder, SR; Hu, RJ
      Treatment with atypical antipsychotics: new indications and new populations

      JOURNAL OF PSYCHIATRIC RESEARCH
    91. Guiso, G; Caccia, S
      Distribution of the methylpiperazinopyridobenzoxazepine derivative JL13, apotential antipsychotic, in rat brain

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    92. Lopez-Gimenez, JF; Vilaro, MT; Palacios, JM; Mengod, G
      Mapping of 5-HT2A receptors and their mRNA in monkey brain: [H-3]MDL100,907 autoradiography and in situ hybridization studies

      JOURNAL OF COMPARATIVE NEUROLOGY
    93. Curran, MP; Perry, CM
      Amisulpride - A review of its use in the management of schizophrenia

      DRUGS
    94. Cookson, J
      Use of antipsychotic drugs and lithium in mania

      BRITISH JOURNAL OF PSYCHIATRY
    95. Dawe, GS; Huff, KD; Vandergriff, JL; Sharp, T; O'Neill, MJ; Rasmussen, K
      Olanzapine activates the rat locus coeruleus: In vivo electrophysiology and c-fos immunoreactivity

      BIOLOGICAL PSYCHIATRY
    96. Wirshing, DA; Pierre, JM; Eyeler, J; Weinbach, J; Wirshing, WC
      Risperidone-associated new-onset diabetes

      BIOLOGICAL PSYCHIATRY
    97. Miller, DD; Andreasen, NC; O'Leary, DS; Watkins, GL; Ponto, LLB; Hichwa, RD
      Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

      BIOLOGICAL PSYCHIATRY
    98. Bertolino, A; Callicott, JH; Mattay, VS; Weidenhammer, KM; Rakow, R; Egan, MF; Weinberger, DR
      The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia

      BIOLOGICAL PSYCHIATRY
    99. Lindamer, LA; Buse, DC; Lohr, JB; Jeste, DV
      Hormone replacement therapy in postmenopausal women with schizophrenia: Positive effect on negative symptoms?

      BIOLOGICAL PSYCHIATRY
    100. Woods, SW; Stolar, M; Sernyak, MJ; Charney, DS
      Consistency of atypical antipsychotic superiority to placebo in recent clinical trials

      BIOLOGICAL PSYCHIATRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 01:32:53